Skip to content

AUTONOMYCS

Active
Private limited companyfounded 2024active for 2 yearsZ. 1 Researchpark 310, 1731 Asse, BelgiumKBO/BCE: BE 1010.365.262
Summary

AUTONOMYCS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€26,095) and a net result of -€86,095. Its solvency ranks better than 5% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Overview

Activity
Nutrition and dietetics services
NACE 86995Other research and development on natural sciences NACE 72109
1 site
Size
€321,347total assets 2025
Equity
-€26,095
Loss
-€86,095
Turnover not published (micro format)
Financial health
54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.5%
Structure
Accounts filed 7 days late
Why 54raises riskCapped at 59: negative equity1 change of registered office in 24 monthsNegative equity -€26,095lowers riskSector: Human health activities (NACE 86)Founded in 2024Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 21% of its sector peers (NACE 86, micro)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Weak
Solvency 17
equity -8.1% of total assets
Liquidity 79
short-term debt 17.7% · cash 26.7%
Profitability 0
return on assets -26.8%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,086 companies, NACE 86, micro)
Last 24 months 07-2025: 0.3% 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.1%▼ -0.2 percentage points vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.3%▲ +0.2 percentage points vs 04-2026 06-2026: 0.4%▲ +0.1 percentage points vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.4%● unchanged vs 07-2026 09-2026: 0.4%● unchanged vs 08-2026 10-2026: 0.5%▲ +0.1 percentage points vs 09-2026highest value
No credit on open account
Liquidity ample (current ratio 1.73, above the usual 1.5; short-term debt: 17.7% and cash: 26.7% of total assets), but equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 3% on solvency, 60% on liquidity and 1% on profitability.

The bankruptcy probability was computed on 20-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Negative equity -€26,095
NBB · annual accounts
lowers risk · Founded in 2024
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Filed after the deadline
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 07-11-2025, 7 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
7 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Resignations: Dri3m (director) and NKO Bornem…Appointment: AMOLITA (day-to-day manager) ·…
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Resignation: Karen Feyen CommV (director)Appointment: Karen Feyen CommV (director)…

Financials · financial year 2025, micro format

2025 annual accounts filed late (7 days) Filed on 7 November 2025, deadline 31 October 2025 (7 months after the close on 31 March 2025, Companies Code art. 3:10). Source: NBB, 2025-00564325.

Equity
-€26,095
Total assets
€321,347
Net result
-€86,095
Working capital
€41,534

Turnover and EBIT margin not published: the micro format does not require them.

Balance-sheet composition
Assets €274,746
Fixed assets €176,260
Current assets €98,485
Equity and liabilities
Equity-€26,095
Debt€347,443
Equity is negative: debt (€347,443) exceeds the balance-sheet total (€321,347).
Key figures and ratios
2025 value
EBITDA
-€69,472
Cash flow
-€71,819
Solvency
-8.1%
Current ratio
1.73
ROA
-26.8%
Interest coverage
-28.88
Debt
€347,443
Debt ≤ 1 year
€56,951
Debt > 1 year
€290,491
No debt to equity: equity is negative, so debt divided by equity means nothing.

Peer companies

Historical observation

Of the 7,639 companies that looked in July 2024 the way this one looks now, 8.8% went bankrupt within 24 months and 84.9% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.8% went bankrupt
5.6% stopped otherwise
84.9% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 40 lines
Balance sheet Code2025
Assets
Total assets20/58€321,347
Formation expenses20€46,602
Fixed assets21/28€176,260
Intangible fixed assets21€40,079
Tangible fixed assets22/27€131,361
Plant, machinery and equipment23€102,368
Furniture and vehicles24€552
Other tangible fixed assets26€28,441
Financial fixed assets28€4,820
Current assets29/58€98,485
Amounts receivable within one year40/41€8,340
Trade receivables40€2,824
Other amounts receivable41€5,517
Cash at bank and in hand54/58€85,812
Deferred charges and accrued income490/1€4,333
Equity and liabilities
Total equity and liabilities10/49€321,347
Equity10/15-€26,095
Contributions10/11€60,000
Profit (loss) carried forward14-€86,095
Amounts payable17/49€347,443
Amounts payable after more than one year17€290,491
Financial debts170/4€290,491
Amounts payable within one year42/48€56,951
Current portion of amounts payable after more than one year42€24,362
Financial debts43€53
Credit institutions430/8€53
Trade debts44€32,537
Suppliers440/4€32,537
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,276
Other operating charges640/8€439
Gross operating margin9900-€69,033
Operating profit (loss)9901-€83,748
Financial income75/76B€57
Recurring financial income75€57
Financial charges65/66B€2,405
Recurring financial charges65€2,405
Profit (loss) for the period before taxes9903-€86,095
Profit (loss) for the period9904-€86,095
Profit (loss) for the period to be appropriated9905-€86,095
Appropriation of the result
Profit (loss) to be appropriated9906-€86,095

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,276
Other operating charges640/8€439
Gross operating margin9900-€69,033
Operating profit (loss)9901-€83,748
Financial income75/76B€57
Recurring financial income75€57
Financial charges65/66B€2,405
Recurring financial charges65€2,405
Profit (loss) for the period before taxes9903-€86,095
Profit (loss) for the period9904-€86,095
Profit (loss) for the period to be appropriated9905-€86,095
Line2025
Assets
Total assets20/58€321,347
Formation expenses20€46,602
Fixed assets21/28€176,260
Intangible fixed assets21€40,079
Tangible fixed assets22/27€131,361
Plant, machinery and equipment23€102,368
Furniture and vehicles24€552
Other tangible fixed assets26€28,441
Financial fixed assets28€4,820
Current assets29/58€98,485
Amounts receivable within one year40/41€8,340
Trade receivables40€2,824
Other amounts receivable41€5,517
Cash at bank and in hand54/58€85,812
Deferred charges and accrued income490/1€4,333
Equity and liabilities
Total equity and liabilities10/49€321,347
Equity10/15-€26,095
Contributions10/11€60,000
Profit (loss) carried forward14-€86,095
Amounts payable17/49€347,443
Amounts payable after more than one year17€290,491
Financial debts170/4€290,491
Amounts payable within one year42/48€56,951
Current portion of amounts payable after more than one year42€24,362
Financial debts43€53
Credit institutions430/8€53
Trade debts44€32,537
Suppliers440/4€32,537
Line2025
Profit (loss) for the period9904-€86,095
+ Depreciation and write-downs630€14,276
Operating cash flow (approximation)-€71,819

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
31-03-2025 micro format 07-11-2025 2025-00564325

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 10,198 active companies whose main activity is nutrition and dietetics services (NACE 86995), figures are known for 872. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 office holder, no change since 2026

Day-to-day management 1

AMOLITA
Day-to-day manager · since 27-04-2026 · Private limited company · permanent representative: ITTERBEEK Patrick
Current

Permanent representatives 1

ITTERBEEK Patrick
Permanent representative · since 27-04-2026 · for AMOLITA
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

3 people since 2026, 1 in office
Show
  • Board
  • Day-to-day management
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
AMOLITA
  • Day-to-day manager, from 27-04-2026 to date
NKO Bornem
  • Director, until 22-02-2026
  • Voorzitter van het bestuursorgaan, until 27-04-2026
DRI3M
  • Director, until 22-02-2026
See the board, name and registered office on a given date →

Owners and capital

Owners

3 owners

Owners 3

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Shareholders according to the deeds
Stated in the act act of 27-04-2026 ↗
  • ITTERBEEK Patrick Martin Henri 50 shares
  • AMOLITA (BE 0869.864.722) 600 shares
  • Benoni VAN BUTSELE 900 shares
  • BIROMED (BE 0719.413.663) 900 shares
  • FEYEN Karen 75 shares
  • Tom FEYEN 50 shares
  • Wito DE GREEF 125 shares
  • Emelyn MATHOT 50 shares
  • Lena HERMANS 50 shares
  • KINEMIE (BE 1019.542.650) 50 shares
  • Elise DANLOIS 50 shares
  • Naomi FAUCONNIER 50 shares
  • Thomas RYCKEBUSCH 50 shares

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 27-04-2026 Capital increase of €300,000 · 3,000 new shares · in cash

Group and network

Connections & network

4 connected companies
Depth
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
CANTILIS
Shared corporate director
→
LeapStation
Shared corporate director
→
PharmaBXL
Shared corporate director
→
Sint-Trudo Ziekenhuis
Shared corporate director
→

History

On 14 June 2024, AUTONOMYCS was incorporated as a private limited company.1 In 2026 the registered office moved to Zellik.2 In 2026 the capital was increased by €300,000.2

  1. 1KBO register
  2. 2Belgian Official Gazette, 27-04-2026

Acts, filings and financial milestones

2026
27-04
Gazette deed Resignations: Dri3m (director) and NKO Bornem (director)
Appointment: AMOLITA (day-to-day manager) · Capital increase · Shareholding20 facts ▸
  • General meeting, 09-04-2026
  • Capital increase, €300,000
  • Shareholding, “gewoon”, 50 (deed in Dutch) (8 times)
  • Shareholding, “gewoon”, 600 (deed in Dutch)
  • Shareholding, “gewoon”, 900 (deed in Dutch) (2 times)
  • Shareholding, “gewoon”, 75 (deed in Dutch)
  • Shareholding, “gewoon”, 125 (deed in Dutch)
  • Bank account, “Belfius bank”, 07-04-2026 (deed in Dutch)
  • Other provision, “waiver of pre-emptive rights, verzaking” (deed in Dutch)
  • Capital
  • Amendment of the articles, 5
  • Other provision, “coördinatie van de statuten opmaken en ondertekenen, neerlegging in vennootschapsdossier, mandate to notary” (deed in Dutch)
  • +8 further facts in this act
2025
07-11
NBB filing Annual accounts filed
financial year 2025 · micro format · 7 days late
22-07
Gazette deed Resignation: Karen Feyen CommV (director)
Appointment: Karen Feyen CommV (director) · Permanent representative: Karen Feyen4 facts ▸
  • General meeting, 13-02-2025
  • Director resignation, Karen Feyen CommV (director)
  • Director appointment, Karen Feyen CommV (director)
  • Permanent representative, Karen Feyen
2024
30-10
Gazette deed Appointments: AMOLITA BV (managing director) and NKO Bornem BV (chair)
Permanent representatives: Patrick Itterbeek, Rafael Jacobs and Etienne Maeriën10 facts ▸
  • Board meeting, 11-07-2024
  • Director appointment, AMOLITA BV (managing director)
  • Permanent representative, Patrick Itterbeek
  • Director appointment, NKO Bornem BV (chair)
  • Permanent representative, Rafael Jacobs
  • Board composition, Karen Feyen (director)
  • Board composition, Dri3m BV (director)
  • Permanent representative, Etienne Maeriën (vertegenwoordigd door)
  • Board composition, NKO Bornem BV (director and chair)
  • Board composition, AMOLITA BV (managing director and director)
18-06
Gazette deed Incorporation
Appointments: FEYEN Karen, Dri3m and 2 others · Permanent representatives: MAERIËN Etienne, JACOBS Raf and ITTERBEEK Patrick · Founder20 facts ▸
  • Incorporation, “AUTONOMYCS” (deed in Dutch)
  • Founder, MAERIËN Etienne August Caroline
  • Founder, FEYEN Karen
  • Founder, ITTERBEEK Patrick Martin Henri
  • Founder, JACOBS Rafael Leo
  • Founder, DE GREEF Wito
  • Founding capital, €60,000
  • Bank account, “vennootschap in oprichting, BE16 7340 7896 4574” (deed in Dutch)
  • Other provision, “funds at disposal”, 60000 (deed in Dutch)
  • Other provision, “statuten, houden onder meer het volgende in” (deed in Dutch)
  • Capital
  • Registered office clause, “Vlaams gewest, 9050 Ledeberg,Ledebergstraat 67” (deed in Dutch)
  • +8 further facts in this act
Gazette deedNBB filing
4 of 4 deeds read

Register details

Identification
Legal formPrivate limited company
Founded14-06-2024
Financial year end31-03
Activities, NACEBEL 2025
72109Other research and development on natural sciences
86995Nutrition and dietetics services
72200Scientific research and development
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID 0208:1010365262
Also 9925:BE1010365262
Registered 16-12-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 21 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Asse · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
9,606 m²
Building footprint
750 m²
Building volume
4,730 m³
Parcel 23095C0033/00Z006, Flanders · tallest building 7.9 m. Linked by address, not a title deed.
8 companies at this address See who is registered here
1 establishment unit
AUTONOMYCS
Z. 1 Researchpark 310, 1731 AsseNutrition and dietetics services
since 2024unit no. 2.360.846.376
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
23095C0033/00Z006 Flanders 9,606 m² 1 · 750 m² 7.9 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
AUTONOMYCS
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaamse Gewest, kan bij enkel besluit bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren vestigen…” (deed in Dutch)

deed of 18-06-2024

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Bestuursorgaan, met of zonder beperking van duur” (deed in Dutch)
“Alle handelingen nodig of nuttig voor verwezenlijking voorwerp, geheel van bevoegdheden” (deed in Dutch)
“Mandaat al dan niet ten kosteloze titel, algemene vergadering” (deed in Dutch)

deed of 18-06-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
One provision in the deed
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Aandelenoverdracht bij leven en overlijden, afzonderlijke aandeelhoudersovereenkomst” (deed in Dutch)

deed of 18-06-2024

Meetings and financial year

Financial yearThe twelve-month period the company draws up its annual accounts for.
From 1 January to 31 December
Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Last Thursday of June at 15:00

deed of 27-04-2026

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
Dissolution ruleWhen and by whom the company can be dissolved.
“Vormen vereist voor statutenwijziging, algemene vergadering” (deed in Dutch)
“Besluiten over ontbinding of aangekondigde continuïteitsmaatregelen, Wetboek van vennootschappen en verenigingen” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Indien geen andere vereffenaar benoemd, behoudens ontbinding en sluiting vereffening in één akte” (deed in Dutch)

deed of 18-06-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

1 more provision in the deed, see the deed of 22-07-2025
1 more provision in the deed, see the deed of 18-06-2024